Financials

  • Market Capitalization 73.83 M
  • Employee 6
  • Founded 2000
  • CEO Yuichi Iwaki
  • Website www.medicinova.com
  • Headquarter Delaware, United States
  • FIGI BBG000RDP030
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.46
Rapporto prezzo/fatturato
156.89

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3982
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.09 USD-0.91%-6.03%-6.03%-33.94%74.96 M USD
3987
HRTX
Heron Therapeutics, Inc. - Common Stock
0.39 USD-7.14%+18.18%+25.81%-70.45%74.04 M USD
4002
PMVP
PMV Pharmaceuticals, Inc. - Common Stock
1.35 USD-4.26%-15.63%-6.90%-4.93%72.17 M USD
4013
MAIA
MAIA Biotechnology, Inc. Common Stock
1.16 USD-1.69%-0.85%-18.31%-44.23%70.56 M USD

Notizie